About Us

A Vision for Better Health

Founded in 2015 in Hyderabad, India, Waterley Pharmaceuticals has grown into a trusted name in healthcare, expanding its operations across Pan India. Our mission is to redefine patient care by bringing innovative ideas, breakthrough products, and transformative services that improve medical outcomes.

  • We collaborate closely with healthcare professionals to ensure access to cutting-edge therapies and healthcare programs.
  • Our focus areas include gastroenterology and other critical therapy fields.
  • Our goal is to help people live longer, healthier lives.
  • Waterley’s leadership team consists of visionary and resourceful professionals with deep pharmaceutical industry expertise.
  • We uphold the highest standards of integrity, ethics, and excellence.
  • We strive to benefit our employees, stakeholders, and communities through our work.

10

Years

Of Experience in the Pharma Industry

OUR VISION

To achieve robust growth through expansion of our operations, while maintaining highest standards of business conduct and commitment to our core values. We strive to do our best through continuous improvement and increasing our presence in the market.

OUR MISSION

To provide innovative therapies to improve quality of life, while operating with the highest standards of integrity and ethics.

ADVANCING GASTROINTESTINAL & LIVER HEALTH

Gastrointestinal diseases have seen a notable rise in prevalence across Asia over the past two decades. These conditions now account for a significant portion of morbidity and mortality in the region. While infectious diseases such as diarrhea, hepatitis, typhoid, and tuberculosis of the intestinal tract remain widespread, there is also an alarming increase in lifestyle-related GI disorders, including:
  • ď„‘Irritable Bowel Syndrome (IBS)
  • ď„‘Gastroesophageal Reflux Disease (GERD)
  • ď„‘Inflammatory Bowel Disease (IBD) like Crohn’s Disease & Ulcerative Colitis
  • ď„‘Non-Alcoholic Fatty Liver Disease (NAFLD)
  • ď„‘Cancers of the Esophagus, Colon, Liver, Pancreas, and Gallbladder
With these rising challenges, Waterley Pharmaceuticals sees a tremendous opportunity to make a meaningful difference. By delivering innovative, high-quality medications, we strive to meet the evolving healthcare needs of patients in India and neighbouring Asian countries.

MILESTONES

10 Years of Pioneering Gastroenterology

2014

Incorporation of Waterley Pharmaceuticals.

2015

Evir (Entecavir), an antiviral for Hepatitis B and Hepkart (Ademetionine), a hepatoprotective launched successfully.

2016

Market Expansion in North Eastern States, India.

2017

Launch of brands - Mycolon Group (Mebeverine) for use in IBS & Cretox CP (Antioxidants with Micronutrients & Methionine) for pain management in Chronic Pancreatitis. Expanded operations in Western & Southern India.

2018

New brands launched - Hepsure (BCAA), Megaley (Omega-3acid Ethyl Esters), Megaley-E (Omega-3 FA+Vit E), Rematin IBD - Specialized nutrition for Inflammatory Bowel Disease.

2019

Launched Bistas (CBS) for treating H. Pylori infection and Dexolan (Dexlansoprazole MR) a new generation PPI.

2021

Launch of Aladrine (Midodrine Hcl) a potent vasopressor and Betadek - a combination of fat-soluble vitamins with Zinc.

2022

Launched Rematin Plus Peptide powder - specialized nutrition for patients iwth G.I. Intolerance.

2024

Launched Rematin Liv protein powder, Lorhep & Tresfix

2025

Launching new emerging specialty Gynec & Derma division - Waterley Healthcare.

MILESTONES

10 Years of Pioneering Gastroenterology

2014

Incorporation of Waterley Pharmaceuticals.

2015

Evir (Entecavir), an antiviral for Hepatitis B and Hepkart (Ademetionine), a hepatoprotective launched successfully.

2016

Market Expansion in North Eastern States, India.

2017

Launch of brands - Mycolon Group (Mebeverine) for use in IBS & Cretox CP (Antioxidants with Micronutrients & Methionine) for pain management in Chronic Pancreatitis. Expanded operations in Western & Southern India.

2018

New brands launched - Hepsure (BCAA), Megaley (Omega-3acid Ethyl Esters), Megaley-E (Omega-3 FA+Vit E), Rematin IBD - Specialized nutrition for Inflammatory Bowel Disease.

2019

Launched Bistas (CBS) for treating H. Pylori infection and Dexolan (Dexlansoprazole MR) a new generation PPI.

2021

Launch of Aladrine (Midodrine Hcl) a potent vasopressor and Betadek - a combination of fat-soluble vitamins with Zinc.

2022

Launched Rematin Plus Peptide powder - specialized nutrition for patients iwth G.I. Intolerance.

2024

Launched Rematin Liv protein powder, Lorhep & Tresfix

2025

Launching new emerging specialty Gynec & Derma division - Waterley Healthcare.

OUR VALUES: WHAT DRIVES US?

At Waterley Pharmaceuticals, our values are the foundation of everything we do. They shape our culture, inspire our people, and define our commitment to improving lives.

TRUST

We believe that trust is the cornerstone of meaningful collaboration. At Waterley, we foster an environment where people feel empowered to share their perspectives openly and honestly. Through transparency and shared values, we build lasting relationships and work together toward a common mission.

TEAMWORK

Great achievements are never the result of individual effort alone—they stem from strong, united teams. We encourage collaboration, respect diverse viewpoints, and harness collective intelligence to drive innovation and success.

RESPECT FOR PEOPLE

Our people are our greatest asset. We cultivate a culture of respect, dignity, and openness, enabling personal and professional growth. By supporting and uplifting one another, we strengthen our organization and its impact on the world.

COMMUNICATION

Clear and effective communication fuels progress. We embrace open dialogue to align diverse ideas with our mission of improving lives. Whether within our teams or in collaboration with healthcare professionals, we continuously refine our communication to build understanding and drive meaningful change.

INTEGRITY

Integrity isn’t just a principle—it’s the backbone of our culture. We hold ourselves to the highest ethical standards, standing by our commitments even in the face of challenges. Honesty, discipline, and resilience define how we operate, ensuring that we always do what is right.

INNOVATION

Innovation is at the heart of progress. We challenge ourselves to think beyond the ordinary, embracing strategic creativity to enhance our products, processes, and services. At Waterley, we see innovation not just as an idea but as a disciplined approach to building a stronger, more capable future—even if it means taking bold risks.

CONTINUOUS LEARNING

Growth is a journey, and learning is the key to unlocking potential. We empower individuals to develop new skills, make informed decisions, and implement innovative solutions. Through education and training, we ensure that our people stay ahead in an ever-evolving industry.
At Waterley Pharmaceuticals, our values aren’t just words—they are the guiding force behind everything we do. They drive our passion, shape our purpose, and inspire us to make a lasting impact in healthcare.

LEADERSHIP

The leadership at Waterley Pharmaceuticals is led by a diverse, dynamic, committed and entrepreneurial team and are experienced professionals with a deep understanding of science and healthcare. We are passionate about developing innovative solutions that improve the lives of patients.

MANISH SUTRAVE

Director

K.P. SHINOD

Director

VENUGOPAL REDDY

Director

MEGHAM REDDY

Director

GANESH KUMAR

Director

JOIN US IN TRANSFORMING HEALTHCARE!

Every innovation we create brings us closer to a world where better health is within reach for all. Let’s make a difference—together.